PPT-Perioperative Transfusion

Stewardship Objectives Discuss risks and outcomes associated with transfusion Describe ASPIRE transfusion measures Provide general recommendations based on American Society of Anesthesiologists ASA Transfusion Guidelines 2015. Ashutosh Lal, MD. Northern California Thalassemia Center. UCSF Benioff Children’s Hospital Oakland. Thalassemia Syndromes: . Many diagnoses. Oakland Data (n=203). What is the proportion of . non-transfusion-dependent thalassemia. Brian Katz MD. Neurovascular Fellow. University of Cincinnati Medical Center. Learning Objectives. Mechanisms and timing of stroke. Procedures and comorbidities associated with perioperative stroke. Clinical management options that . Based on the Patient Blood Management Guidelines. Be. . SINGLE . m. inded. Patient Blood Management Guidelines. www.blood.gov.au. . Single Unit. Transfusion Guideline. WHO . The stable, normovolaemic inpatient who . Orracha. . Kok. -. Kaew. , MD.. Anesthesiologist. Objectives. สามารถอธิบายถึงกลไกของร่างกายในการตอบสนองต่อการภาวะ . An Evidence-Based . Approach. Haneen . Yasin. Abdella, MD. Hematology Oncology . Kidz. Medical Services. Miami Children’s Hospital. Objectives. Review the definite indications for . leukoreduced. “Blood transfusion is like marriage: it should not be entered upon lightly, unadvisedly or wantonly or more often than is absolutely necessary. .” . . –Robert Beal, past director of International Federation of Red Cross. Which is the Culprit for Worse Outcomes in Cardiac Surgery?. Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, . Alan M. . Speir. MD, Mohammed . Quader. , MD, Irving L. . Kron. MD, . Elizabeth S. Allen, MD. Outline. Platelets. Problems with Platelets. Pathogen Reduced Platelets. UCSD Implementation Strategy. Objectives. Understand the risks of conventional platelet transfusion. Describe the mechanism and effects of pathogen reduction technology. Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction?. Jeannie Callum, BA, MD, FRCPC. Really?. Are we still talking. about this in 2017?. Disclosure. Reduce Complications of . Prematurity. . A . Multi-site Quality Improvement Project. Sponsored . by the Indiana State Department of . Health. . Presenter: Sandra Hoesli, MD, MS. Objectives. Describe the Indiana Vermont Oxford Network Quality Collaborative (. . Daradka. University Of Jordan. School Of Medicine. General . S. urgery Department . A Transfusion Dilemma. A 72 year old woman presents to ER with a nosebleed. This is her second visit in 24 hours with the same complaint. Her nose is packed and the bleeding stops.. Released October 2014 Table of ContentsIntroductionDevelopment of a Massive Transfusion Protocol: Engagement and ScopeTriggers for Initiating Massive TransfusionBlood Product Resuscitation in the Trau Objectives. Discuss risks and outcomes associated with transfusion . Describe ASPIRE transfusion measures. Provide general recommendations based on American Society of Anesthesiologists (ASA) Transfusion Guidelines (2015). Faculty and Disclosures. 2. AORN is pleased to collaborate with Victoria . Steelman. , PhD, RN, CNOR, . FAAN, . and . The . University of Iowa . to make this Prevention of Perioperative . Hypothermia .